Welcome to CDC stacks | Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain - 31886 | Preventing Chronic Disease
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain
Filetype[PDF-271.90 KB]


Details:
  • Personal Authors:
  • Keywords:
  • Pubmed ID:
    26068412
  • Pubmed Central ID:
    PMC4467257
  • Description:
    Adding aromatase inhibitors (AIs) to adjuvant treatment of postmenopausal women with hormone-receptor-positive breast cancer significantly reduces cancer recurrence. A common side effect of AIs is noninflammatory joint pain and stiffness (arthralgia) similar to arthritis symptoms. An evidence-based walking program developed by the Arthritis Foundation - Walk With Ease (WWE) - reduces arthritis-related joint symptoms. We hypothesized that WWE may also reduce AI-associated arthralgia. However, the potential for different barriers and facilitators to physical activity for these 2 patient populations suggested a need to adapt WWE before testing it with breast cancer survivors. We conducted qualitative research with 46 breast cancer survivors to explore program modification and inform the development of materials for an adapted program (Walk With Ease-Breast Cancer). Our process parallels the National Cancer Institute's Research-Tested Intervention Programs (RTIPs) guidelines for adapting evidence-based programs for cancer populations. Findings resulted in a customized 8-page brochure to supplement existing WWE materials.

  • Document Type:
    Journal Article
  • Collection(s):
    Preventing Chronic Disease
No Related Documents.
You May Also Like:
  1. Physical Distress and Cancer Care Experiences Among Chinese-American and Non-Hispanic White Breast Cancer Survivors
    Personal Author:
    Wang, Judy Huei-yu; Adams, Inez; Huang, Ellen; Ashing-Giwa, Kimlin; Gomez, Scarlett Lin; Allen, Laura;
    Published:
    Nov 22 2011
    Source:
    Gynecol Oncol. 2011; 124(3):383-388.
    Description:
    Objective : The number of Chinese-American breast cancer survivors (BCS) is increasing as a result of increasing incidence rates. There has been little research on Chinese BCS’ follow-up cancer care. This qualitative study aims to understand how Ch...
    File Type:
    Filetype[PDF - 313.13 KB]
  2. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    Personal Author:
    Dizon, Don S.; Krilov, Lada; Cohen, Ezra; Gangadhar, Tara; Ganz, Patricia A.; Hensing, Thomas A.; Hunger, Stephen; Krishnamurthi, Smitha S.; Lassman, Andrew B.; Markham, Merry Jennifer; Mayer, Erica; Neuss, Michael; Pal, Sumanta Kumar; Richardson, Lisa C.; Schilsky, Richard; Schwartz, Gary K.; Spriggs, David R.; Villalona-Calero, Miguel Angel; Villani, Gina; Masters, Gregory;
    Published:
    Feb 04 2016
    Source:
    J Clin Oncol. 34(9):987-1011.
    File Type:
    Filetype[PDF - 692.37 KB]
  3. Coming Soon
    SOCIOECONOMIC STATUS AND BREAST CANCER TREATMENT
    Personal Author:
    Dreyer, Marie S.; Nattinger, Ann B.; McGinley, Emily L.; Pezzin, Liliana E.;
    Published:
    Sep 07 2017
    Source:
    Breast Cancer Res Treat. 167(1):1-8.
    Description:
    Purpose : Evidence suggests substantial disparities in breast cancer survival by socioeconomic status (SES). We examine the extent to which receipt of newer, less invasive, or more effective treatments – a plausible source of disparities in surviva...
    Public Access
    Available on:
    January 01, 2019
  4. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study
    Personal Author:
    Clarke, Christina A.; Canchola, Alison J.; Moy, Lisa M.; Neuhausen, Susan L.; Chung, Nadia T.; Lacey, James V.; Bernstein, Leslie;
    Published:
    May 01 2017
    Source:
    Breast Cancer Res. 19.
    Description:
    Background : Regular users of aspirin may have reduced risk of breast cancer. Few studies have addressed whether risk reduction pertains to specific breast cancer subtypes defined jointly by hormone receptor (estrogen and progesterone receptor) and h...
    File Type:
    Filetype[PDF - 411.58 KB]
  5. U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition
    Personal Author:
    Curtis, Kathryn M.
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 18, 2010
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2010; 59(RR-4):1-86.
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-4
    Description:
    "CDC created U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, from guidance developed by the World Health Organization (WHO) and finalized the recommendations after consultation with a group of health professionals who met in Atlanta, G...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.35 MB]